These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20923947)

  • 1. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate.
    Andrus MR; Gilbert E
    Ann Pharmacother; 2010 Nov; 44(11):1810-6. PubMed ID: 20923947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
    Lindley SE; Carlson EB; Hill K
    J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate in combat-related posttraumatic stress disorder.
    Alderman CP; McCarthy LC; Condon JT; Marwood AC; Fuller JR
    Ann Pharmacother; 2009 Apr; 43(4):635-41. PubMed ID: 19336652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.
    Berlant JL
    BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
    Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
    BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.
    Tucker P; Trautman RP; Wyatt DB; Thompson J; Wu SC; Capece JA; Rosenthal NR
    J Clin Psychiatry; 2007 Feb; 68(2):201-6. PubMed ID: 17335317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.
    Berlant J; van Kammen DP
    J Clin Psychiatry; 2002 Jan; 63(1):15-20. PubMed ID: 11838620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
    Watts BV; Schnurr PP; Mayo L; Young-Xu Y; Weeks WB; Friedman MJ
    J Clin Psychiatry; 2013 Jun; 74(6):e541-50. PubMed ID: 23842024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label study of mirtazapine as treatment for combat-related PTSD.
    Alderman CP; Condon JT; Gilbert AL
    Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baclofen treatment for chronic posttraumatic stress disorder.
    Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
    Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in posttraumatic stress disorder: preliminary clinical observations.
    Berlant JL
    J Clin Psychiatry; 2001; 62 Suppl 17():60-3. PubMed ID: 11495099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
    Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A
    J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
    Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G
    Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN; Gershon S; Levine J
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.
    Yeh MS; Mari JJ; Costa MC; Andreoli SB; Bressan RA; Mello MF
    CNS Neurosci Ther; 2011 Oct; 17(5):305-10. PubMed ID: 21554564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate Monotherapy for Civilian Posttraumatic Stress Disorder: A Controlled Pilot Study.
    Monga V; Petty F; Padala K; Padala PR
    Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37857291
    [No Abstract]   [Full Text] [Related]  

  • 17. An open-label assessment of aripiprazole in the treatment of PTSD.
    Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
    Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans.
    Davis LL; Ward C; Rasmusson A; Newell JM; Frazier E; Southwick SM
    Psychopharmacol Bull; 2008; 41(1):8-18. PubMed ID: 18362867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.